Article Details

US FDA approves Daiichi Sankyo-AstraZeneca's Enhertu for lung cancer

Retrieved on: 2022-08-12 11:30:14

Tags for this article:

Click the tags to see associated articles and topics

US FDA approves Daiichi Sankyo-AstraZeneca's Enhertu for lung cancer. View article details on HISWAI: https://www.pharmaceutical-technology.com/news/fda-enhertu-lung-cancer/

Excerpt

The US FDA has granted approval for Daiichi Sankyo and AstraZeneca's Enhertu to treat unresectable or metastatic non-small cell lung cancer.

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up